Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesMedicus Pharma Ltd. Common Stock

Medicus Pharma Ltd. Common Stock

Healthcare Drug Manufacturers - General
PortfolioPortfolio WatchlistWatchlist
Company price
2.03 USD 0.10 ( 5.18%)
Last update at 2026-11-03T21:00:00Z
VOLUME
25864
Market Cap
10.91M

Momentum Score

…

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.90
Low
2.12
High
52 Week Price Range
0.14
Low
3.05
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
1.93
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-59.15
ROE
-7446.11%
Net Debt
-4.71M
ROCE
-14881.51%
Diluted EPS TTM
-2.26

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -25.37M -11.16M -5.31M -1.69M -2.06M
Minority interest 0.00M 0.00M - - -
Net income -25.37M -11.16M -5.31M -1.69M -2.06M
Selling general administrative 17.92M 7.65M 2.46M 0.33M 0.26M
Ebit - -11.18M -2.66M -0.98M -1.44M
Ebitda -25.23M -11.16M -0.59M -1.17M -1.94M
Depreciation and amortization - - 2.07M - -
Operating income -18.35M -11.18M -4.73M -0.98M -1.44M
Other operating expenses 18.35M 11.18M 4.73M 0.98M 1.44M
Interest expense 0.14M 0.32M 0.60M 0.53M 0.12M
Interest income - 0.10M - - -
Net interest income -0.20M 0.03M -0.58M -1.10M -0.69M
Total revenue 0.00M 0.00M 0.00M 0.00M 0.00M
Total operating expenses 18.35M 11.18M 4.73M 0.98M 1.44M
Total other income expense net -7.02M 0.03M -0.58M -0.71M -0.61M
Net income from continuing ops -35.44M -11.16M -5.31M -1.69M -2.06M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 10.06M 5.65M 1.89M 0.28M 0.08M
Other current assets 1.19M 1.21M 0.17M 0.01M -
Total liab 10.02M 2.51M 0.78M 12.48M 10.58M
Total stockholder equity -0.07M 3.13M 1.11M -12.20M -10.51M
Other current liab 2.57M 0.91M 0.57M 10.95M 9.92M
Common stock 57.08M 30.52M 18.76M 0.19M 0.19M
Capital stock 57.39M 30.52M 18.76M 0.19M 0.19M
Retained earnings -64.35M -28.90M -17.75M -12.39M -10.70M
Cash 8.71M 4.16M 1.72M 0.27M 0.08M
Total current liabilities 9.94M 2.31M 0.78M 12.48M 10.58M
Net debt -4.71M -3.84M -1.72M 1.26M 0.59M
Short term debt 3.93M 0.12M - 1.53M 0.67M
Short long term debt 5.25M - - 1.53M 0.67M
Short long term debt total 4.00M 0.32M - 1.53M 0.67M
Other stockholder equity 7.19M 1.52M 0.10M - -
Total current assets 9.89M 5.38M 1.89M 0.28M 0.08M
Long term debt 0.03M - - - -
Accounts payable 3.44M 1.28M 0.21M - -
Accumulated other comprehensive income 0.01M - - - -
Non current assets total 0.17M 0.27M 0.00M 0.00M 0.00M
Capital lease obligations 0.21M 0.32M 0.00M - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total cashflows from investing activities -4.62M - - - -
Net borrowings 4.48M 5.17M 0.50M 1.25M 0.88M
Total cash from financing activities 31.94M 12.69M 5.61M 1.25M 0.88M
Net income -35.44M -11.16M -5.31M -1.69M -2.06M
Change in cash 4.54M 2.44M 1.45M 0.19M -0.57M
Begin period cash flow 4.16M 1.72M 0.27M 0.08M 0.64M
End period cash flow 8.71M 4.16M 1.72M 0.27M 0.08M
Total cash from operating activities -22.78M -10.25M -4.16M -1.06M -1.45M
Issuance of capital stock 18.22M 7.52M 0.00M - -
Other cashflows from financing activities 9.08M - 5.11M - -
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.41M 0.03M 0.47M -0.08M -0.01M
Stock based compensation 1.51M 0.71M 0.10M 0.00M -
Other non cash items 10.75M 0.16M 0.58M 0.71M 0.61M
Free cash flow -22.78M -10.25M -4.16M -1.06M -1.45M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - General

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
MDCX
Medicus Pharma Ltd. Common Stock		 0.10
5.18%		 2.03 - - - 11.97
LLY
Eli Lilly and Company		 -1.60
0.11%		 1409.39 38.16 24.15 12.72 29.95
JNJ
Johnson & Johnson		 -4.40
1.63%		 266.16 30.96 20.79 6.58 7.55
ABBV
AbbVie Inc		 -2.84
0.98%		 286.00 74.10 16.21 7.22 50.46
RHHVF
Roche Holding AG Participation		 -10.00
2.06%		 475.00 24.16 16.53 5.71 8.88

Profile*

Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.

300 Conshohocken State Road, West Conshohocken, PA, United States, 19428

610 636 0184

https://medicuspharma.com

16

Name Title Year Born
Dr. Raza Bokhari M.B.A., M.D. CEO & Executive Chairman 1968
Dr. Edward J. Brennan Jr., F.A.C.S., M.D. Chief Scientific Officer and Head of R&D Program 1961
Dr. Faisal Mehmud M.D. Chief Medical Officer 1975
Mr. Andrew Alasdair Smith Chief Operating Officer 1969
Ms. Anna Baran-Djokovic J.D. Senior Vice President of Investor Relations NA
Ms. Viktoria Slepeniuk Senior Vice President of Public Relations NA
Ms. Maryann Adesso Chief of Staff & Corporate Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

VNP
CAD 32.54
+24.44%
HUT
CAD 88.32
+14.81%
KEEL
CAD 3.05
+14.66%
MTY
CAD 36.63
+13.58%
CNL
CAD 15.98
+11.90%
MOON
CAD 4.72
-12.34%
EU
CAD 0.96
-8.57%
URE
CAD 1.02
-8.48%
AP-UN
CAD 3.71
-8.17%
HG
CAD 3.77
-8.05%

Equity Sectors*

  • Basic Materials

    -1.14%

  • Communication Services

    +0.65%

  • Consumer Cyclical

    +0.09%

  • Consumer Defensive

    -0.57%

  • Energy

    -0.15%

  • Financial Services

    +0.08%

  • Healthcare

    +2.18%

  • Industrials

    +2.04%

  • Real Estate

    -0.25%

  • Technology

    +1.02%

  • Utilities

    +0.66%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…